Full-Time

Director of AI for Clinical Trial Design and Optimization

Confirmed live in the last 24 hours

Sanofi

Sanofi

10,001+ employees

Global healthcare provider of medicines and vaccines

Biotechnology
Healthcare

Senior, Expert

Toronto, ON, Canada

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
LLM
Agile
Data Science
Apache Spark
Machine Learning
AWS
Natural Language Processing (NLP)
Databricks
Google Cloud Platform

You match the following Sanofi's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • PhD or MSc in computer science, machine learning, computational biology or related area with at least 6 years of experience in working on the development of methods related to deep NN, LLMs, generative AI or related topics
  • Knowledge of the biomedical domain
  • Knowledge of the clinical trial process is an advantage
  • Experience in the use of AI for NLP and text analysis and in use cases downstream of NLP LLMs
  • Demonstrated ability to lead a team of data scientists and generate software solutions that are of practical use
  • Hands-on AI/ML modeling experience of complex datasets combined with strong understanding of theoretical foundations of AI/ML
  • Experience developing deployable code and deploying models in product-focused development under an agile environment
  • Comfortable working in cloud and high-performance computing environments (e.g. AWS, GCP, Databricks, Apache Spark)
  • Excellent written and verbal communication, business analysis, data visualization and data storytelling skills
  • Strong interest in the use of AI in the life and medical sciences to improve patient lives.
Responsibilities
  • Lead a team of AI/ML and software engineers to evaluate, develop, extend and apply advance ML / AI methods for Clinical Trial design, analysis and optimization.
  • Develop, implement, test and refine advanced AI/ML methods for the processing, analysis, modeling integration and visualization of large-scale biomedical data including text, imaging and omics data.
  • Use AI and ML methods for knowledge extraction from text and other structured data and for integrating this data with other types of structure and unstructured data using multi-modal genAI methods.
  • Be in close contact with our clinical teams to discuss requirements, possible solutions and ways to integrate the proposed AI / ML methods to improve clinical trial design and execution.
  • Work closely with the leading generative AI companies (our vendors) to make sure our products are state of the art and up to date.
  • Work with developers, engineers, and MLOps to deliver AI/ML solutions to product teams.
Desired Qualifications
  • Knowledge of the clinical trial process is an advantage.

Sanofi provides healthcare solutions through its pharmaceutical and biotechnology products, focusing on treatments and vaccines for various medical needs. The company conducts extensive research and development to create new therapies and improve existing ones, particularly in areas like immunology, oncology, and rare diseases. Sanofi's products include prescription medicines, over-the-counter items, and vaccines, which are distributed to patients, healthcare professionals, and governments. What sets Sanofi apart from its competitors is its strong emphasis on scientific innovation and strategic partnerships, allowing it to maintain a diverse product pipeline. The company's goal is to enhance health outcomes and improve the quality of life for people globally.

Company Stage

IPO

Total Funding

$2B

Headquarters

Paris, France

Founded

1973

Simplify Jobs

Simplify's Take

What believers are saying

  • FDA Breakthrough Therapy designation for tolebrutinib boosts Sanofi's neurology leadership.
  • Sanofi's Muse AI tool accelerates patient recruitment, reducing clinical trial timelines.
  • Investment in Zucara Therapeutics strengthens Sanofi's diabetes portfolio with innovative treatments.

What critics are saying

  • Regulatory delays in Japan and China for Sarclisa could impact revenue projections.
  • Liver enzyme elevations in tolebrutinib trials may lead to regulatory scrutiny.
  • Reliance on strategic partnerships poses risks if expected results are not achieved.

What makes Sanofi unique

  • Sanofi's Sarclisa is the first anti-CD38 therapy combined with VRd in the EU.
  • The Care4Rare program focuses on lysosomal storage diseases, offering unique patient solutions.
  • Sanofi's MyWay app enhances patient engagement and medication adherence through digital health.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Professional Development Budget

Parental Leave